Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats

Journal of the Peripheral Nervous System

Volumn 4, Issue 3-4, 1999, Pages 211-221

  Mizisin, Andrew P ^a,c   Calcutt, Nigel A ^a   Tomlinson, David R ^b   Gallagher, Alex ^b   Fernyhough, Paul ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Axonal caliber; Experimental diabetic neuropathy; Myelinated fibers; Neurofilament phosphorylation; Neurotrophin; NT 3

Indexed keywords

NEUROTROPHIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; HYPERGLYCEMIA; INSULIN TREATMENT; NERVE CONDUCTION; NERVE FIBER; NERVE INJURY; NEUROFILAMENT; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR AFFINITY; SCIATIC NERVE; STREPTOZOCIN DIABETES;

ANIMALS; AXONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; INSULIN; MALE; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; NEUROFILAMENT PROTEINS; NEUROTROPHIN 3; PERONEAL NERVE; PHOSPHORYLATION; RATS; RATS, WISTAR; SCIATIC NERVE; SPINAL NERVE ROOTS; SURAL NERVE;

EID: 0033380731     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Munson JB, Shelton DL, McMahon SB: Adult mammalian sensory and motor neurons: Roles of endogenous neurotrophins and rescue by exogenous neurotrophins after axotomy. J. Neurosci. 1997;17:470-476.
2. Ohara S, Tantuwaya V, DiStefano PS, Schmidt RE: Exogenous NT-3 mitigates the transganglionic neuropeptide Y response to sciatic nerve injury. Brain Res. 1995;699:143-148.
3. Groves MJ, An SF, Giometto B, Scaravilli F: Inhibition of sensory neuron apoptosis and prevention of loss by NT-3 administration following axotomy. Exp. Neurol. 1999;155:284-294.
4. Ljungberg C, Novikov L, Kellerth JO, Ebendal T, Wiberg M: The neurotrophins NGF and NT-3 reduce sensory neuronal loss in adult rat after peripheral nerve lesion. Neurosci. Lett. 1999;262:29-32.
5. Sterne GD, Brown RA, Green CJ, Terenghi G: Neurotrophin-3 delivered locally via fibronectin mats enhances peripheral nerve regeneration. Eur. J. Neurosci. 1997;9:1388-1396.
6. Gao WQ, Dybal N, Shinsky N, Murane A, Schmelzer C, Siegel M, Keller G, Hefti F, Phillips HS, Winslow JW: Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann. Neurol. 1995;38:30-37.
7. Helgren ME, Cliffer KD, Torrento K, Cavnor C, Curtis R, DiStefano PS, Wiegand SJ, Lindsay RM: Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy. J. Neurosci. 1997;17:372-382.
8. Hellweg R, Hartung H-D: Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 1990; 26:258-267.
9. Calcutt NA, Muir D, Powell HC, Mizisin AP: Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Res. 1992; 575:320-324.
10. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR: Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J. Neurochem. 1995;64:1231-1237.
11. Fernyhough P, Diemel LT, Tomlinson DR: Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 1998;41:300-306.
12. Rodriguez-Pena A, Botana M, Gonzalez M, Requejo F: Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats. Neurosci. Lett. 1995;200:37-40.
13. Ihara C, Shimatsu A, Mizuta H, Murabe H, Nakamura Y, Nakao K: Decreased neurotrophin-3 expression in skeletal muscles of streptozotocin-induced diabetic rats. Neuropeptides 1996;30:309-312.
14. Mizisin AP, Calcutt NA, DiStefano PS, Longo FM: Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats. Diabetes 1997;46:647-652.
15. Mizisin AP, DiStefano PS, Lui X, Garrett D, Tonra JR: Decreased accumulation of endogenous brain-derived neurotrophic factor against constricting sciatic nerve ligatures in streptozotocin-diabetic and galactose-fed rats. Neurosci. Lett. 1999;263:1-4.
16. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR: Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Mol. Brain Res. 1995;21:171-175.
17. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA: Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 1994;634:7-12.
18. Whitworth IH, Terenghi G, Green CJ, Brown RA, Stevens E, Tomlinson DR: Targeted delivery of nerve growth factor via fibronectin conduits assists nerve regeneration in control and diabetic rats. Eur. J. Neurosci. 1995;7:2220-2225.
19. Mizisin AP, Bache M, DiStefano PS, Acheson A, Lindsay RM, Calcutt NA: BDNF attenuates functional and structural disorders in nerves of galactose-fed rats. J. Neuropathol. Exp. Neurol. 1997;56:1290-1301.
20. Mizisin AP, Kalichman MW, Bache M, Dines KC, DiStefano PS: NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats. J. Neuropathol. Exp. Neurol. 1998;57:803-813.
21. Gasser HS, Grundfest H: Axon diameters in relation to spike dimensions and the conduction velocity in mammalian A fibers. Am. J. Physiol. 1939;127:393-414.
22. Glicksman MA, Soppert D, Willard MB: Posttranslational modification of neurofilament polypeptides in rabbit retina. J. Neurobiol. 1987;18:167-196.
23. Fernyhough P, Gallagher A, Averill SA, Priestley JV, Hounsom L, Patel J, Tomlinson DR: Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 1999;48:881-889.
24. Cork LC, Sternberger NH, Sternberger LA, Casanova MF, Struble RG, Price DL: Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 1986;45: 56-64.
25. Price J: An immunohistochemical and quantitative examination of dorsal root ganglion neuronal cell populations. J. Neurosci. 1985;5:2051-2059.
26. Nixon RA, Paskevich PA, Sihag RK, Thayer CY: Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing and axonal caliber. J. Cell Biol. 1994;126:1031-1046.
27. Tomlinson DR, Fernyhough P, Diemel LT: Neurotrophins and peripheral neuropathy. Phil Trans. Royal Soc. Lond. Series B: Biol. Sci. 1996;351:455-462.
28. DiStefano PS, Friedman B, Radziejewski C, Alexander C, Boland P, Schick CM, Lindsay RM, Wiegand SJ: The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 1992;8:983-993.
29. Yan Q, Elliot JL, Matheson C, Sun J, Zhang L, Mu X, Rex KL, Snider WD: Influences of neurotrophins on mammalian motoneurons in vivo. J. Neurobiol. 1993;24:1555-1557.
30. Henderson CE, Camu W, Mettling C, Gouin A, Poulsen K, Karihaloo M, Rullamas J, Evans T, McMahon SB, Armanini AP, Berkemeier L, Phillips HS, Rosenthal A: Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993; 363:266-270.
31. Apfel SC, Arezzo JC, Moran M, Kessler JA: Effects of administration of ciliary neurotrophic factor on normal motor and sensory nerves in vivo. Brain Res. 1993;604:1-6.
32. Waxman SG: Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve 1980;3:141-150.
33. Brismar T, Sima AAF, Greene DA: Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann. Neurol. 1987;21:504-507.
34. Cameron NE, Cotter MA: Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: Evidence from experimental studies. Diabetic Med. 1993;10:593-605.
35. Green DA, Lattimer SA, Sima AAF: Sorbitol, phospho-inositides and sodium-potassium ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 1987;316:599-606.
36. Calcutt NA, Dines KC, Cesena RM: Effects of the peptide HP288 on nerve disorders in diabetic rats. Metabolism 1998;47:650-656.
37. Calcutt NA, Campana WM, Eskeland NL, Mohiuddin L, Dines KC, Mizisin AP, O'Brien JS: Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats. J. Neuropathol. Exp. Neurol. 1999;58:556-564.
38. Mendell LM, Johnson RD, Munson JB: Neurotrophin modulation of the monosynaptic reflex after peripheral nerve transection. J. Neurosci. 1999;19:3162-3170.
39. Friede R, Samorajski T: Axon caliber related to neurofilament and microtubules in sciatic nerve. Anat. Rec. 1970;167:379-388.
40. Hoffman PN, Koo EH, Muma NA, Griffin JW, Price DL: Role of neurofilaments in the control of axonal caliber in myelinated nerve fibers. In: Intrinsic Determinants of Neuronal Form and Function (Lasek RJ, Black MM, eds). New York: Alan R Liss, 1988, 389-402.
41. Mohiuddin L, Fernyhough P, Tomlinson DR: Reduced levels of mRNA encoding endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes. Diabetes 1995;44:25-30.
42. Larsen, JR, Sidenius P: Slow axonal transport of structural polypeptides in rat, early changes in streptozocin diabetes, and effect of insulin treatment. J. Neurochem. 1989;52:390-401.
43. Macioce P, Filliatreau G, Figliomeni B, Hassig R, Thiery J, DiGamberardino L: Slow axonal transport impairment of cytoskeletal proteins in streptozotocin-induced diabetic neuropathy. J. Neurochem. 1989;53: 1261-1267.
44. Medori R, Jenich H, Autilio-Gambetti L, Gambetti P: Experimental diabetic neuropathy: Similar changes of slow axonal transport and axonal size in different animal models. J. Neurosci. 1988;8:1814-1821.
45. Yagihashi S, Kamijo M, Watanabe K: Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am. J. Pathol. 1990;136: 1365-1373.